Avera Innovations in the Management of Cancer Conference – A Focus on Breast

National and international experts will convene at Avera in Sioux Falls, South Dakota on June 16 and 17 to discuss the latest techniques in breast cancer treatment.

The conference will focus on the role of genomics, oncoplastic surgery techniques, electron-based intraoperative radiation therapy, neoadjuvant chemotherapy, and the future of surgery and radiation oncology. Attendees will include Surgeons, Radiation Oncologists, Medical Oncologists, and representatives from pharmaceuticals.

The course directors include Julie Reiland, MD, FACS, who specializes in breast cancer treatment and technology at Avera, and Brian Leyland-Jones, MB BS PhD, Vice President of Avera Cancer Institute for Precision Oncology and Vice President of Molecular and Experimental Medicine at Avera.

Fred Ashbury, PhD, Co-founder and Chief Scientific Officer at Viviphi, will join the afternoon panel on June 16 to discuss the role of genomics in breast cancer treatment. 

All sessions will be held at the Prairie Center at Avera: 1000 E. 23rd St. Sioux Falls, SD 57105. 

Registration and more information can be found at the Avera conference website.

 

Media Caption

Avera Innovations in Management of Cancer Conference

Agenda for Innovations in Management of Cancer Conference

Agenda for Innovations in Management of Cancer Conference